Highlights
NASDAQ: AXSM       Axsome Thera
Last Price Today's Change   Day's Range   Trading Volume
24.42   -0.15 (0.61%)  24.15 - 25.10  291,310

Overview

 
Avg Volume (4 weeks):808,725
4 Weeks Range:20.022 - 26.435
4 Weeks Price Volatility (%):
68.58%
52 Weeks Range:1.94 - 30.50
52 Weeks Price Volatility (%):
78.71%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Axsome Therapeutics Inc is a United States-based healthcare service provider. As a pre-clinical therapeutics developer, the company attends primarily to central nervous system disorders such as Alzheimer's. Its product portfolio consists of novel drugs like the AXS-02 (disodium zoledronate tetrahydrate), which is an oral, non-opioid therapeutic for chronic pain and the AXS-05, which is a fixed-dose combination of dextromethorphan and bupropion. The AXS-02 addresses pain in over three conditions, such as complex regional pain syndrome, knee osteoarthritis and chronic low back pain. The AXS-05 on the other hand, treats resistant depression and agitation in patients with Alzheimer's disease. Both the products have passed the preclinical, Phase 1 and Phase 2 stages of development.

  Be the first to like this.
 


 

2954  2614  494  2908 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.827+0.282 
 AMD 37.52+0.81 
 ET 11.16-0.50 
 GE 11.29-0.13 
 AABA 19.630.00 
 DIS 148.72+10.14 
 BAC 32.79-0.30 
 F 8.81-0.23 
 UBER 26.71+0.01 
Partners & Brokers